Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, James S Andersen, Brian C Baumann, Jeremy Bordeaux, Pei-Ling Chen, Robert Chin, Carlo M Contreras, Dominick DiMaio, Jessica M Donigan, Jeffrey M Farma, Karthik Ghosh, Roy C Grekin, Kelly Harms, Alan L Ho, Ashley Holder, John Nicholas Lukens, Theresa Medina, Kishwer S Nehal, Paul Nghiem, Soo Park, Tejesh Patel, Igor Puzanov, Jeffrey Scott, Aleksandar Sekulic, Ashok R Shaha, Divya Srivastava, William Stebbins, Valencia Thomas, Yaohui G Xu, Beth McCullough, Mary A Dwyer, Mai Q Nguyen
{"title":"NCCN指南®见解:鳞状细胞皮肤癌，版本1.2022。","authors":"Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, James S Andersen, Brian C Baumann, Jeremy Bordeaux, Pei-Ling Chen, Robert Chin, Carlo M Contreras, Dominick DiMaio, Jessica M Donigan, Jeffrey M Farma, Karthik Ghosh, Roy C Grekin, Kelly Harms, Alan L Ho, Ashley Holder, John Nicholas Lukens, Theresa Medina, Kishwer S Nehal, Paul Nghiem, Soo Park, Tejesh Patel, Igor Puzanov, Jeffrey Scott, Aleksandar Sekulic, Ashok R Shaha, Divya Srivastava, William Stebbins, Valencia Thomas, Yaohui G Xu, Beth McCullough, Mary A Dwyer, Mai Q Nguyen","doi":"10.6004/jnccn.2021.0059","DOIUrl":null,"url":null,"abstract":"<p><p>The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.</p>","PeriodicalId":520697,"journal":{"name":"Journal of the National Comprehensive Cancer Network : JNCCN","volume":" ","pages":"1382-1394"},"PeriodicalIF":16.4000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"48","resultStr":"{\"title\":\"NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.\",\"authors\":\"Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, James S Andersen, Brian C Baumann, Jeremy Bordeaux, Pei-Ling Chen, Robert Chin, Carlo M Contreras, Dominick DiMaio, Jessica M Donigan, Jeffrey M Farma, Karthik Ghosh, Roy C Grekin, Kelly Harms, Alan L Ho, Ashley Holder, John Nicholas Lukens, Theresa Medina, Kishwer S Nehal, Paul Nghiem, Soo Park, Tejesh Patel, Igor Puzanov, Jeffrey Scott, Aleksandar Sekulic, Ashok R Shaha, Divya Srivastava, William Stebbins, Valencia Thomas, Yaohui G Xu, Beth McCullough, Mary A Dwyer, Mai Q Nguyen\",\"doi\":\"10.6004/jnccn.2021.0059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.</p>\",\"PeriodicalId\":520697,\"journal\":{\"name\":\"Journal of the National Comprehensive Cancer Network : JNCCN\",\"volume\":\" \",\"pages\":\"1382-1394\"},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"48\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the National Comprehensive Cancer Network : JNCCN\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.6004/jnccn.2021.0059\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Comprehensive Cancer Network : JNCCN","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6004/jnccn.2021.0059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
